Skip to main content

Table 3 The Response Rate in the Trial and Control Group for Different Type of Tumors

From: The effect of chemotherapy combined with recombination mutant human tumor necrosis factor on advanced cancer

 

Group

n

CR

PR

MR

SD

PD

Response rate

p*

NSCLC

Trial

17

1

7

3

4

2

47.06% (8/17)

0.208

 

Control

6

0

1

1

3

1

16.67% (1/6)

 

Gastric cancer

Trial

32

0

4

6

13

9

12.50% (4/32)

0.283

 

Control

18

0

0

2

9

7

0.00 (0/18)

 

Colorectal cancer

Trial

20

0

1

2

10

7

5.00% (1/20)

1.000

 

Control

12

0

0

1

7

4

0.00 (0/12)

 
  1. *The p value is calculated by Fisher exact chi-square because n < 30 or some cells have expected count less than 1.